loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X

List of Drug Master Files (JDMF) for Camostatum Active Pharmaceutical Ingredient (API) submitted to the Review Authority in Japan (PMDA). Original Data : PMDA Database

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 ERREGIERRE S. p. A. (1)

filter

01 "Japan-station" mesylate camostat (production only) (1)

filter

01 Italy (1)

URL Supplier Web Content
217MF11176
VIA F. BARACCA 19-24060 SAN PAOLO D...
2018-05-01
2005-12-12
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for 59721-28-7 / Camostatum API manufacturers, exporters & distributors?

Camostatum manufacturers, exporters & distributors 1

18

PharmaCompass offers a list of Camostatum API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Camostatum manufacturer or Camostatum supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Camostatum manufacturer or Camostatum supplier.

PharmaCompass also assists you with knowing the Camostatum API Price utilized in the formulation of products. Camostatum API Price is not always fixed or binding as the Camostatum Price is obtained through a variety of data sources. The Camostatum Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Camostatum

Synonyms

59721-28-7, Camostat [inn], Camostate, [4-[2-[2-(dimethylamino)-2-oxoethoxy]-2-oxoethyl]phenyl] 4-(diaminomethylideneamino)benzoate, 0fd207wkdu, 4-(2-(2-(dimethylamino)-2-oxoethoxy)-2-oxoethyl)phenyl 4-guanidinobenzoate

Cas Number

59721-28-7

Unique Ingredient Identifier (UNII)

0FD207WKDU

About Camostatum

Camostat is an orally bioavailable, synthetic serine protease inhibitor, with anti-inflammatory, antifibrotic, and potential antiviral activities. Upon oral administration, camostat and its metabolite 4-(4-guanidinobenzoyloxyl)phenyl acetic acid (FOY 251) inhibit the activities of a variety of proteases, including trypsin, kallikrein, thrombin and plasmin, and C1r- and C1 esterases. Although the mechanism of action of camostat is not fully understood, trypsinogen activation in the pancreas is known to be a trigger reaction in the development of pancreatitis. Camostat blocks the activation of trypsinogen to trypsin and the inflammatory cascade that follows. Camostat may also suppress the expression of the cytokines interleukin-1beta (IL-1b), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-a) and transforming growth factor-beta (TGF-beta), along with alpha-smooth muscle actin (alpha-SMA). This reduces inflammation and fibrosis of the pancreas. In addition, camostat may inhibit the activity of transmembrane protease, serine 2 (TMPRSS2), a host cell serine protease that mediates viral cell entry for influenza virus and coronavirus, thereby inhibiting viral infection and replication.

Camostatum Manufacturers

A Camostatum manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Camostatum, including repackagers and relabelers. The FDA regulates Camostatum manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Camostatum API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

Camostatum Suppliers

A Camostatum supplier is an individual or a company that provides Camostatum active pharmaceutical ingredient (API) or Camostatum finished formulations upon request. The Camostatum suppliers may include Camostatum API manufacturers, exporters, distributors and traders.

click here to find a list of Camostatum suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Camostatum JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Camostatum Drug Master File in Japan (Camostatum JDMF) empowers Camostatum API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Camostatum JDMF during the approval evaluation for pharmaceutical products. At the time of Camostatum JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Camostatum suppliers with JDMF on PharmaCompass.

Camostatum Manufacturers | Traders | Suppliers

Camostatum Manufacturers, Traders, Suppliers 1
38

We have 1 companies offering Camostatum

Get in contact with the supplier of your choice:

  1. Erregierre SpA
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Post Enquiry
POST ENQUIRY